221 related articles for article (PubMed ID: 2142915)
1. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
Browne GJ; Trieu L; Van Asperen P
Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
[TBL] [Abstract][Full Text] [Related]
3. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
[TBL] [Abstract][Full Text] [Related]
4. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
5. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
[TBL] [Abstract][Full Text] [Related]
6. Nebulized ipratropium in the treatment of acute asthma.
Summers QA; Tarala RA
Chest; 1990 Feb; 97(2):425-9. PubMed ID: 2137076
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer.
Rodrigo C; Rodrigo G
Chest; 1994 Oct; 106(4):1071-6. PubMed ID: 7924475
[TBL] [Abstract][Full Text] [Related]
9. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
O'Driscoll BR; Taylor RJ; Horsley MG; Chambers DK; Bernstein A
Lancet; 1989 Jun; 1(8652):1418-20. PubMed ID: 2567431
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.
Schuh S; Johnson DW; Callahan S; Canny G; Levison H
J Pediatr; 1995 Apr; 126(4):639-45. PubMed ID: 7699549
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
[TBL] [Abstract][Full Text] [Related]
13. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
14. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
[TBL] [Abstract][Full Text] [Related]
15. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.
Garrett JE; Town GI; Rodwell P; Kelly AM
J Allergy Clin Immunol; 1997 Aug; 100(2):165-70. PubMed ID: 9275135
[TBL] [Abstract][Full Text] [Related]
16. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
18. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
[TBL] [Abstract][Full Text] [Related]
19. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.
Rebuck AS; Chapman KR; Abboud R; Pare PD; Kreisman H; Wolkove N; Vickerson F
Am J Med; 1987 Jan; 82(1):59-64. PubMed ID: 2879458
[TBL] [Abstract][Full Text] [Related]
20. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
